1. Home
  2. ESPR vs GDEV Comparison

ESPR vs GDEV Comparison

Compare ESPR & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.31

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Logo GDEV Inc.

GDEV

GDEV Inc.

N/A

Current Price

$14.61

Market Cap

289.9M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ESPR
GDEV
Founded
2008
2009
Country
United States
Cyprus
Employees
N/A
589
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
731.9M
289.9M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ESPR
GDEV
Price
$2.31
$14.61
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$7.60
N/A
AVG Volume (30 Days)
5.3M
1.1K
Earning Date
05-05-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
60.71
N/A
EPS
N/A
N/A
Revenue
$403,135,000.00
N/A
Revenue This Year
$2.92
$8.56
Revenue Next Year
N/A
$8.05
P/E Ratio
N/A
$5.19
Revenue Growth
21.31
N/A
52 Week Low
$0.73
$8.81
52 Week High
$4.18
$42.20

Technical Indicators

Market Signals
Indicator
ESPR
GDEV
Relative Strength Index (RSI) 33.99 51.83
Support Level $1.02 $14.41
Resistance Level $3.02 $16.51
Average True Range (ATR) 0.20 0.70
MACD 0.00 0.17
Stochastic Oscillator 17.40 86.06

Price Performance

Historical Comparison
ESPR
GDEV

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About GDEV GDEV Inc.

GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.

Share on Social Networks: